Pulsed Field Ablation · Houston, TX
Pulsed field ablation for AFib.
Pulsed field ablation is the newest way to treat atrial fibrillation, and the first genuinely different one in two decades. Below is a straight account of what it does well and where the evidence is still thin.
How PFA is different
Electricity, not temperature.
Radiofrequency and cryoablation both work by temperature, heating or freezing tissue until it stops conducting. Temperature does not discriminate between heart muscle and whatever sits next to it, which is why the esophagus, phrenic nerve, and pulmonary veins are the structures electrophysiologists watch most closely.
Electroporation
PFA uses very short, high-voltage electrical pulses that open pores in cell membranes. Heart muscle is more susceptible to this effect at a given energy than nerve or esophageal tissue.
Selectivity is the point
That difference in susceptibility is the entire reason the technique was developed.
First fluoroless PulseSelect PVI in Houston
Dr. Boone performed Houston's first fluoroless PulseSelect pulsed field ablation pulmonary vein isolation.
FDA approved
Multiple pulsed field ablation systems hold FDA approval for treating atrial fibrillation in the United States.
What the evidence shows
The findings, with sources.
Every comparative claim below is attributed to a published study. Long-term data on PFA is still maturing, and any honest account has to say so.
Pulmonary vein narrowing
In ADVENT, the first randomized trial comparing PFA against thermal ablation, pulmonary vein cross-sectional area decreased 0.9% with PFA versus 12% with thermal ablation at three months. No patient in either arm developed severe stenosis. (Mansour et al., Europace, 2024)
Esophageal injury
A meta-analysis of 18 studies and 4,998 patients found substantially lower rates of esophageal injury with PFA than with thermal ablation. (de Campos et al., Heart Rhythm O2, 2024)
Procedure time
PFA procedures run shorter on average, though with longer fluoroscopy time in most reported series. (Aldaas et al., J Interv Card Electrophysiol, 2023)
Effectiveness
The 2024 meta-analysis found a better first-pass isolation rate and a modestly lower treatment failure rate with PFA. An earlier meta-analysis found no significant difference in recurrence. The honest summary: at least as effective, with long-term data still accumulating.
Better than cryoablation?
A tool, not a treatment plan.
For most patients undergoing a first pulmonary vein isolation, PFA offers a favorable safety profile around the esophagus and pulmonary veins with comparable or slightly better effectiveness. That makes it a strong default for straightforward paroxysmal AFib. It is not universally better.
Where PFA fits well
Symptomatic paroxysmal AFib, drug-refractory or drug-intolerant AFib, a first pulmonary vein isolation, and cases where esophageal proximity is a particular concern.
Where radiofrequency still wins
Complex atrial arrhythmias, repeat procedures, and ablation outside the pulmonary veins, where point-by-point control matters more.
Where cryoablation still wins
A longer track record and years more follow-up data behind it.
Cases needing discussion
Long-standing persistent AFib, a prior failed ablation, arrhythmias other than AFib, and unusual pulmonary vein anatomy.
Medically reviewed by David Boone, MD
Board certified in Cardiovascular Disease and in Clinical Cardiac Electrophysiology by the American Board of Internal Medicine. Fellowship-trained in clinical cardiac electrophysiology at UTHealth Houston. Last reviewed: August 2026.
Next step
Request a consultation.
New patients and physician referrals are always welcome. No referral is required, and same-week appointments are generally available at all three offices.